All products are for Professional Use Only (PUO) — not intended for human or animal consumption

Back to Learn
Metabolic & Weight ManagementPeptide

Semaglutide

An extensively studied GLP-1 receptor agonist with a long half-life enabling once-weekly dosing. Research has investigated its GLP-1 receptor-mediated effects on metabolic signaling pathways and incretin pharmacology.

Mechanism of Action

Semaglutide is a modified GLP-1 analog with 94% homology to native GLP-1. A C-18 fatty diacid chain enables albumin binding, extending its half-life to approximately 7 days. It activates the GLP-1 receptor in the hypothalamus and brainstem to modulate satiety signaling and food intake behavior, modulates gastric emptying kinetics, and enhances glucose-dependent insulin secretion from pancreatic beta cells. The compound also modulates glucagon secretion during hyperglycemia. These combined mechanisms produce sustained effects on metabolic signaling pathways and glycemic regulation.

Research Applications

  • Studies have investigated GLP-1 receptor-mediated effects on metabolic signaling pathways
  • Research has examined cardiovascular biomarker outcomes associated with incretin receptor pharmacology
  • Studies have explored effects on hepatic lipid metabolism and steatosis markers
  • Research has investigated neurological signaling effects including potential neuroprotective pathways

Key Published Studies

1

Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.

Key finding: Research investigated GLP-1 receptor-mediated effects on metabolic signaling pathways in a large-scale study, examining the relationship between incretin receptor activation and downstream metabolic parameters.

2

Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.

Key finding: Research examined the relationship between GLP-1 receptor activation and cardiovascular signaling pathways, investigating potential cardioprotective mechanisms beyond direct metabolic effects.

Chemical Properties

TypePeptide (GLP-1 analog)
CAS Number910463-68-2

Research Use Only (RUO): This page summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. The compound described carries a Research Use Only designation and is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in the diagnosis, treatment, cure, or prevention of any disease. Consult qualified professionals before making any health-related decisions.

i2b Health Research Supply
RESEARCH USE ONLY

Age Verification Required

You must be 21 years of age or older to access this website. All products are intended for qualified researchers and laboratory use only.

By entering this site, you confirm that you are at least 21 years of age, that anything you acquire here is for research purposes, and that you agree to our Terms of Service and Research Use Only policy. Products are not intended for human or animal consumption.